Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study

✍ Scribed by Hye Jin Kang; Won Seog Kim; Seok Jin Kim; Je-Jung Lee; Deok-Hwan Yang; Jin Seok Kim; Se-Ryeon Lee; Gyeong-Won Lee; Hyo Jung Kim; Ho Young Kim; Sung Yong Oh; Hugh Chul Kim; Hyeon-Seok Eom; Jooseop Chung; Jinny Park; Cheolwon Suh; Baek-Yeol Ryoo

• Publisher: Springer
• Year: 2011
• Tongue: English
• Weight: 184 KB
• Volume: 91
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s00277-011-1337-6